menu

Archief Medisch nieuws

RSS-feed van deze nieuwsrubriek

Australië: doorbraak in screening van mesothelioom

25-03-2005 00:00

Australische onderzoekers hebben een bloedtest ontwikkeld die kan helpen bij het opsporen van mesothelioom. De niet invasieve test, Mesomark genaamd, werd ontwikkeld door onderzoekers van de Universiteit van West Australië. In Australië krijgen ongeveer 700 mensen per jaar deze ziekte.

Bron: The Advertiser, 20 april / The West Australian, 19 april.

The Advertiser

April 20, 2005 Wednesday

HEADLINE: Breakthrough

AUSTRALIAN researchers have developed a world-first blood test which could help people worldwide in the early detection of mesothelioma, a deadly asbestos-related cancer of the lung lining. The non-invasive blood test developed by University of Western Australia Professor Bruce Robinson and researchers is a breakthrough in the early detection of the disease. About 700 people each year are diagnosed with the disease in Australia, which has the highest reported incidence in the world.



The West Australian (Perth)

April 19, 2005 Tuesday

HEADLINE: Test offers hope on mesothelioma

Rockingham man David Saw believes a new blood test for mesothelioma, which is being launched today, could have saved him a three-day hospital visit and a lot of trauma.

Mr Saw went to his doctor last year believing he had pulled a muscle.

He was suffering chest pain and shortness of breath.

After a CAT scan and biopsy, it was revealed the 49-year-old had contracted the deadly lung cancer from working with asbestos as a young man.

"A test would have been a lot easier, I ended up in hospital and they had to cut me open," he said.

The test, called MESOMARK, will be available from general practitioners or specialists who can order it from a pathology provider.

The head of the mesothelioma research team at Sir Charles Gairdner Hospital which developed the test, Professor Bruce Robinson, said it would not only help in diagnoses of the disease, but also in treatment.

"Until now you could only gauge whether treatment was working effectively by doing a CAT scan, and they're difficult to do. With this test, we can gauge treatment and also diagnose it at an earlier stage," Professor Robinson said. Biopsy would be needed to confirm diagnosis.

The blood test measures levels of a substance called soluble mesothelin-related peptide, a distinctive biomarker released by mesothelioma cells.

About 700 Australians are diagnosed with the disease every year and WA has the highest rate of mesothelioma in the world.

Asbestos Diseases Society of Australia president Robert Vojakovic said the test could help the possible 6000 people who were children in Wittenoom when the town still had an active blue asbestos mine.